Nearly 9 million teenagers age 12 to 17 have gotten the Pfizer-BioNTech vaccination, which is the sole one approved for that age category as of July 16. 91 percent of the 9,240 recorded adverse effects are modest like pain around the injection area.
The US Centers for Disease Control and Prevention announced Friday that 9percent of the cases are severe, with 4 percent having myocarditis a medical condition.
Serious Side Effects From Pfizer Shots For US Teens Are Rare
The efficacy of the COVID-19 vaccination in younger individuals has been confirmed by US healthcare professionals: Severe adverse effects were uncommon amid the millions of US teenagers who had gotten Pfizer’s injections.
“Local and systemic reactions are common among teenagers after receiving the Pfizer-BioNTech vaccine, particularly after the second dose; nevertheless, major adverse effects following COVID-19 vaccination are uncommon,” stated Anne Hause, a CDC epidemiologist who led the study.
Although this link might appear concerning, CDC officials continue to emphasize the importance of the vaccine for all individuals age 12 and up. For young children, the vaccination has never yet be licensed.
“The benefits of vaccination in reducing COVID-19 and associated sequelae continue to outweigh the risk of uncommon adverse events recorded following vaccination,” she said.
In many instances, it is noted that most people are scared of having a shot due to its so-called side effects but after much research, it is cleared that there are no such effects on people of any age. Hence the efficacy rate of such vaccine increases which proves a good step for the authorities to counter the spread of infection.
Those who were of the opinion of side effects also need to rethink as this survey is conducted in different areas and checked the effects on children of different ages.
Research released last week on the online site medRxiv indicated that youths are more likely to have cardiac swelling before receiving COVID-19 than after receiving the immunization. Scientists compared the frequencies of cardiac swelling in around 14,000 teens identified with COVID-19 with a comparable proportion of immunized teenagers who had adverse symptoms. When opposed to the vaccine group, the probability of cardiac swelling is 21 times greater in females with COVID and around 6 percent more in males having COVID.
“Vaccinating 12- to 17-year-olds remains the safer choice for this age group and will reduce school interruptions and transmission to others,” said Mendel Singer, vice chair for education at Case Western Reserve University School of Medicine in Cleveland and co-author of the medRxiv study.
“You need to put it in perspective. First of all, it appears roughly only one in 20,000 recipients who are in the highest risk group will develop myocarditis after two shots,” he said.
“Myocarditis never sounds good. You can say mild myocarditis all you want, but it’s also going to scare people because the inflammation of the heart muscle is always going to be seen as worrisome. But it does appear to be self-limiting, short-lived, not fatal, and not associated with coronary artery abnormalities,” Offit said.
According to him, a study conducted of 1,600 student-athletes with COVID-19 discovered almost one in 43 developed myocarditis. “So you have basically one in 20,000 phenomena at its peak for the vaccine and a one in 43 phenomena with the disease.”
He went on to say that certain experts think that within decades, you’ll only 2 alternatives: be immunized or get ill organically. “Vaccination is the safer choice because natural infection also causes myocarditis at a much higher rate,” he said.
The CDC’s Morbidity and Mortality Weekly Review issued the report on July 30.